MTOR and central nervous system cancer: Recent reports have identified mixed transcriptional states in the TAM population in glioma patients (Szulzewsky et al, 2015, 2016; Gabrusiewicz et al, 2016), and here, we identify mTOR signalling as a key driver of this intratumoral TAM heterogeneity.